Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience

Journal article

Open access

Peer reviewed

Egyptian Rheumatology and Rehabilitation, Vol.49(1), pp.1-7

2022

Abstract

Children

Juvenile idiopathic arthritis

mRNA COVID-19 vaccine

Safety

SARS-CoV-2

url

https://doi.org/10.1186/s43166-022-00143-zView

Published (Version of record) Open

1 Record Views

Title: Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience
Creators - without role: Abobakr A. Abdelgalil - King Abdulaziz University
Reima A. Bakry - King Fahad Hospital Jeddah
Mohammed A. Muzaffer - King Abdulaziz University
Publication Details: Egyptian Rheumatology and Rehabilitation, Vol.49(1), pp.1-7
Publisher: Springer Berlin Heidelberg
Identifiers: 9931154308331
Academic Unit: Umm Al Qura University; King Abdulaziz University
Language: English
Resource Type: Journal article